J. Derek Lewis & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
J. Derek Lewis & Associates's LLY Position: Q3 2026 in Review
J. Derek Lewis & Associates reduced its Eli Lilly (LLY) stake by 1.2% in Q3 2026, selling an estimated $16.5K and leaving 1,123 shares worth $1.3M. The position accounts for 0.23% of the portfolio, ranked #53.
J. Derek Lewis & Associates first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.36M in Q2 2026. 4,616 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- J. Derek Lewis & Associates held 1,123 shares of Eli Lilly worth $1.3M as of Q3 2026.
- J. Derek Lewis & Associates sold 14 Eli Lilly shares in Q3 2026, an estimated $16.5K.
- Eli Lilly made up 0.23% of J. Derek Lewis & Associates's portfolio in Q3 2026, its #53 holding.
- J. Derek Lewis & Associates first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
- J. Derek Lewis & Associates's Eli Lilly position peaked at $1.36M in Q2 2026.
- 4,616 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on J. Derek Lewis & Associates's 13F filing for Q3 2026, filed 3 Nov 2026.